Yield10 Bioscience

Yield10 Bioscience, Inc. operates as an agricultural bioscience company. It focuses on the development of technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. The company was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P. Peoples in June 1992 and is headquartered in Woburn, MA.

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Yield10 Bioscience, Inc. is an agricultural bioscience company, which engages in the development of oilseed Camelina sativa as a platform crop for large scale production of low carbon sustainable seed products. The company was founded by Anthony J. Sinskey, Simon F. Williams, and Oliver P. Peoples in 1992 and is headquartered in Woburn, MA.

-Second field trial confirms Camelina tolerance to over-the-top herbicide application

Yield10 Bioscience Announces Key Advancements in the Development of Herbicide Tolerant Camelina Supporting Large Acreage Production of Low-carbon Intensity Feedstock Oil for the Biofuel Market

WOBURN, MA / ACCESSWIRE / February 16, 2023 / Yield10 Bioscience, Inc. (NASDAQ:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, has been invited to present at the Third Annual Winter Wonderland - Best Ideas 2023 Virtual Conference, which is being held virtually on February 21st through February 24th, 2023. Yield10 CEO Oliver Peoples, Ph.D.

Yield10 Bioscience to Present at the Third Annual Winter Wonderland - Best Ideas 2023 Virtual Conference on February 21, 2023

WOBURN, Mass., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that it has signed with Mitsubishi Corporation (“Mitsubishi”) a Memorandum of Understanding (“MOU”) to evaluate the establishment of a partnership to supply, offtake and market Camelina as a low-carbon feedstock oil for biofuels. Mitsubishi Corporation recently announced its aim to mass produce sustainable aviation fuel to decarbonize commercial aviation.

Yield10 Bioscience and Mitsubishi Corporation Sign MOU to Evaluate the Establishment of a Partnership to Supply, Offtake and Market Camelina as a Feedstock Oil for Biofuel

Benson Hill

Alkaline Water Company Inc (The)

Yield10 Bioscience (YTEN), The Alkaline Water Company (WTER) and Benson Hill (BHIL) are low-priced and well-ranked consumer staple companies, which look well-placed for 2023 on the back of their robust fundamentals.

3 Under-$3 Consumer Staple Stocks Wall Street Analysts Recommend Buying

WOBURN, Mass., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will present a corporate overview at the Canaccord Genuity AgriFood Tech Innovation Virtual Forum on December 1, 2022 at 1:30pm ET.

Yield10 Bioscience to Present at the CG AgriFood Tech Innovation Virtual Forum

Yield10 Bioscience, Inc. (NASDAQ:YTEN ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Lynne Brum – Vice President of Planning and Corporate Communications Oliver Peoples – President and Chief Executive Officer Kristi Snell – Vice President of Research and Chief Science Officer Chuck Haaser – Chief Accounting Officer Conference Call Participants Anthony Vendetti – Maxim Group Ben Klieve – Lake Street Capital Markets Operator Welcome to the Third Quarter 2022 Financial Results and Business Update Conference Call for Yield10 Bioscience. During the call, participants will be in a listen-only mode.

Yield10 Bioscience, Inc. (YTEN) Q3 2022 Earnings Call Transcript

Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of -1.43% and 26%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Metabolix, Inc. (YTEN) Reports Q3 Loss, Misses Revenue Estimates

-Grower contracts in place for winter 2022/2023 -Development of herbicide tolerance traits in Camelina on track -Collaboration with Rothamsted Research for omega-3 technology extended through 2023

Yield10 Bioscience Announces Third Quarter 2022 Financial Results

-Advancing development of herbicide tolerant Camelina-

Yield10 Bioscience Begins Winter 2022/2023 Field Test and Seed Production Program

WOBURN, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its third quarter 2022 financial results and provide a corporate update on Monday, November 14, 2022.

Yield10 Bioscience to Announce Third Quarter 2022 Financial Results and Host a Conference Call on Monday, November 14, 2022

WOBURN, MA / ACCESSWIRE / October 6, 2022 / Yield10 Bioscience, Inc. (NASDAQ:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, has been invited to present at the MicroCap Rodeo presents: The Windy City Roundup 2022 investor conference, which is being held in-person on October 12th - 13th, 2022. Yield10 is scheduled to present on Wednesday, October 12, 2022 at 3:30 pm CDT (4:30 pm EDT).

Yield10 Bioscience to Present at the MicroCap Rodeo Presents: Windy City Roundup 2022 on October 12

WOBURN, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that Willie Loh, Ph.D., was named to the Company's Board of Directors effective October 4, 2022. Dr. Loh previously served as a Special Commercial and Technical Advisor to the Company. Dr. Loh was formerly Vice President, Market Development of Cargill Inc.'s Global Edible Oils Solutions group in North America. Cargill is a global food and agriculture company.

Yield10 Bioscience Appoints Willie Loh, Ph.D., Former Cargill Executive, to the Board of Directors

WOBURN, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will present during the International Symposium on Biopolymers (“ISBP”) 2022 Conference. The event is taking place September 12 through September 16, 2022 in Sion, Switzerland.

Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advancements in Producing PHA Bioplastic in Camelina at the ISBP 2022 Conference

WOBURN, Mass., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will present a corporate overview at the 24th Annual H.C. Wainwright Global Investment Conference on September 13, 2022 at 2:00 pm ET. The conference is being held on September 12 – 14, 2022 at the Lotte New York Palace Hotel.

Yield10 Bioscience to Present at the 24th Annual H.C. Wainwright Global Investment Conference

Yield10 Bioscience, Inc. (NASDAQ:YTEN ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Lynne Brum - VP, Planning & Corporate Communications & Secretary Oliver Peoples - Co-Founder, President, CEO & Director Kristi Snell - VP, & Chief Science Officer Charles Haaser - VP, Finance, CAO & Treasurer Conference Call Participants Anthony Vendetti - Maxim Group Benjamin Klieve - Lake Street Capital Markets Sameer Joshi - H.C. Wainwright & Co. Operator Welcome to the second quarter 2022 Financial Results and Business Update Conference Call for Yield10 Bioscience.

Yield10 Bioscience, Inc. (YTEN) CEO Oliver Peoples on Q2 2022 Results - Earnings Call Transcript

Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of -1.45% and 37.20%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Metabolix, Inc. (YTEN) Reports Q2 Loss, Misses Revenue Estimates

-Winter program targeting more than 1,000 acres through grower contracts

Yield10 Bioscience Announces Second Quarter 2022 Financial Results

WOBURN, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its second quarter 2022 financial results and provide a corporate update on Wednesday, August 10, 2022.

Yield10 Bioscience to Announce Second Quarter 2022 Financial Results and Host a Conference Call on Wednesday, August 10, 2022

WOBURN, Mass. and SASKATOON, Saskatchewan, July 12, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10 Bioscience” or the “Company”), an agricultural bioscience company, today announced the name change of its wholly-owned Canadian subsidiary to Yield10 Oilseeds Inc. from Metabolix Oilseeds, Inc. effective July 12, 2022. This name change creates an alignment of Yield10 Bioscience's Canadian subsidiary with the branding associated with the Yield10 Bioscience business, which is focused on innovation in oilseed crops to develop crop-based solutions to address global food security, climate change and plastic waste in the environment.

Yield10 Bioscience Changes the Name of its Canadian Subsidiary to Yield10 Oilseeds Inc.

WOBURN, Mass., June 15, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will present during the CROPS 2022: Improving Agriculture Through Genomics Conference taking place June 13 through June 16, 2022 in Huntsville, Alabama.

Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advancements in Producing PHA Bioplastic in Camelina at the CROPS 2022: Improving Agriculture Through Genomics Conference

Archer-Daniels-Midland Company

Adecoagro

Corteva Inc

Calavo Growers

The Agriculture - Operations industry shows potential on solid demand trends, organic product growth and innovation ability. Players like ADM, CTVA, YTEN, AGRO and CVGW have placed themselves well.

5 Stocks to Watch on Robust Agriculture Operations Industry Trends

WOBURN, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will present a corporate overview at the H.C. Wainwright Global Hybrid Investment Conference. The conference is being held on May 23 – 26, 2022 at the Fontainebleau Hotel in Miami Beach, FL.

Yield10 Bioscience to Present at the H.C. Wainwright Global Hybrid Investment Conference

Yield10 Bioscience, Inc. (NASDAQ:YTEN ) Q1 2022 Results Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Lynne Brum - Vice President, Planning and Corporate Communications Oliver Peoples - President and Chief Executive Officer Kristi Snell - Vice President, Research and Chief Science Officer Charles Haaser - Vice President, Finance and Chief Accounting Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Anthony Vendetti - Maxim Group Michael Irwin - Univest Securities, LLC Operator Welcome to the First Quarter 2022 Financial Results and Business Update Conference Call for Yield10 Bioscience. During the call, participants will be in a listen-only mode.

Yield10 Bioscience, Inc. (YTEN) CEO Oliver Peoples on Q1 2022 Results - Earnings Call Transcript

Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of -3.03% and 10.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Metabolix, Inc. (YTEN) Reports Q1 Loss, Misses Revenue Estimates

-Management will host a conference call today at 4:30 p.m. (ET) to review financial results and provide a corporate update

News for Yield10 Bioscience Stock (YTEN)